Literature DB >> 18670795

Reversible dysfunction of retinal ganglion cells in non-secreting pituitary tumors.

Lori M Ventura1, Frank X Venzara, Vittorio Porciatti.   

Abstract

A large cohort of patients participated in a longitudinal study of early glaucoma progression. During follow up, six eyes of three patients displayed a relatively rapid deterioration of pattern electroretinogram (PERG) signal compared to changes in visual acuity, IOP, Standard Automated Perimetry, and Retinal Nerve Fiber Layer thickness measured by OCT. This deterioration prompted further testing including magnetic resonance imaging (MRI), which revealed pituitary tumors in all three patients, two of which were abutting but not compressing the chiasm. Following tumor resection, the PERG signal gradually recovered to baseline values in all six eyes. Results indicate that pituitary tumors may cause retrograde dysfunction of retinal ganglion cells (RGC) even in the absence of visible mechanical compression of the visual pathway, and such dysfunction may be reversed by tumor reduction. The results suggest that PERG is a useful tool in the early diagnosis and management of patients with chiasmal mass lesions.

Entities:  

Mesh:

Year:  2008        PMID: 18670795      PMCID: PMC3707133          DOI: 10.1007/s10633-008-9143-8

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  24 in total

1.  Circulation and axonal transport in the optic nerve.

Authors:  J E Morgan
Journal:  Eye (Lond)       Date:  2004-11       Impact factor: 3.775

Review 2.  Diagnosis and treatment of pituitary adenomas.

Authors:  P Chanson; S Salenave
Journal:  Minerva Endocrinol       Date:  2004-12       Impact factor: 2.184

3.  Relationship between retinal nerve fiber layer and visual field sensitivity as measured by optical coherence tomography in chiasmal compression.

Authors:  Helen V Danesh-Meyer; Stuart C Carroll; Rod Foroozan; Peter J Savino; Jennifer Fan; Yannan Jiang; Stephen Vander Hoorn
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-11       Impact factor: 4.799

4.  Early impairment of foveal magno- and parvocellular pathways in juxta chiasmal tumours.

Authors:  N J Gutowski; J R Heron; M O Scase
Journal:  Vision Res       Date:  1997-05       Impact factor: 1.886

5.  Prognostic value of the pattern electroretinogram in cases of tumors affecting the optic pathway.

Authors:  K Rüther; P Ehlich; A Philipp; A Eckstein; E Zrenner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1998-04       Impact factor: 3.117

6.  Ischemic model of optic nerve injury.

Authors:  George A Cioffi
Journal:  Trans Am Ophthalmol Soc       Date:  2005

7.  Pattern electroretinogram abnormality and glaucoma.

Authors:  Lori M Ventura; Vittorio Porciatti; Kyoko Ishida; William J Feuer; Richard K Parrish
Journal:  Ophthalmology       Date:  2005-01       Impact factor: 12.079

8.  Restoration of retinal ganglion cell function in early glaucoma after intraocular pressure reduction: a pilot study.

Authors:  Lori M Ventura; Vittorio Porciatti
Journal:  Ophthalmology       Date:  2005-01       Impact factor: 12.079

9.  A mechanical theory to account for bitemporal hemianopia from chiasmal compression.

Authors:  Gawn G McIlwaine; Zia I Carrim; Christian J Lueck; T Malcolm Chrisp
Journal:  J Neuroophthalmol       Date:  2005-03       Impact factor: 3.042

Review 10.  Pattern electroretinogram in glaucoma.

Authors:  Lori M Ventura; Vittorio Porciatti
Journal:  Curr Opin Ophthalmol       Date:  2006-04       Impact factor: 3.761

View more
  17 in total

1.  Relationship between macular ganglion cell complex parameters and visual field parameters after tumor resection in chiasmal compression.

Authors:  Shinji Ohkubo; Tomomi Higashide; Hisashi Takeda; Eiji Murotani; Yasuhiko Hayashi; Kazuhisa Sugiyama
Journal:  Jpn J Ophthalmol       Date:  2012-01       Impact factor: 2.447

2.  Predictive factors of visual function recovery after pituitary adenoma resection: a literature review and Meta-analysis.

Authors:  Min Sun; Zhi-Qiang Zhang; Chi-Yuan Ma; Sui-Hua Chen; Xin-Jian Chen
Journal:  Int J Ophthalmol       Date:  2017-11-18       Impact factor: 1.779

3.  Demonstration of reversible retinal ganglion cell dysfunction in inflammatory optic neuropathies utilizing pattern electroretinography.

Authors:  Austin Bach; Matthew D Kay
Journal:  Int J Ophthalmol       Date:  2017-02-18       Impact factor: 1.779

4.  Evaluation of the retinal nerve fibre layer and ganglion cell complex thickness in pituitary macroadenomas without optic chiasmal compression.

Authors:  G Cennamo; R S Auriemma; D Cardone; L F S Grasso; N Velotti; C Simeoli; C Di Somma; R Pivonello; A Colao; G de Crecchio
Journal:  Eye (Lond)       Date:  2015-03-27       Impact factor: 3.775

5.  14th EUNOS Congress: PORTO, PORTUGAL, 16-19 JUNE 2019.

Authors: 
Journal:  Neuroophthalmology       Date:  2019-06-07

6.  Retinal ganglion cell dysfunction in asymptomatic G11778A: Leber hereditary optic neuropathy.

Authors:  John Guy; William J Feuer; Vittorio Porciatti; Joyce Schiffman; Fawzi Abukhalil; Ruth Vandenbroucke; Potyra R Rosa; Byron L Lam
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-10       Impact factor: 4.799

7.  Leber hereditary optic neuropathy gene therapy clinical trial recruitment: year 1.

Authors:  Byron L Lam; William J Feuer; Fawzi Abukhalil; Vittorio Porciatti; William W Hauswirth; John Guy
Journal:  Arch Ophthalmol       Date:  2010-09

8.  A new mouse model of inducible, chronic retinal ganglion cell dysfunction not associated with cell death.

Authors:  Xu Yang; Tsung-Han Chou; Marco Ruggeri; Vittorio Porciatti
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-28       Impact factor: 4.799

9.  Retrograde signaling in the optic nerve is necessary for electrical responsiveness of retinal ganglion cells.

Authors:  Tsung-Han Chou; Kevin K Park; Xueting Luo; Vittorio Porciatti
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-01       Impact factor: 4.799

10.  Visual improvement following glaucoma surgery: a case report.

Authors:  William S Foulsham; Lanxing Fu; Andrew J Tatham
Journal:  BMC Ophthalmol       Date:  2014-12-23       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.